138 related articles for article (PubMed ID: 23998518)
1. Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.
Wang Y; Zhang L; Chen WL; Wang JH; Li N; Li JM; Mi JQ; Zhang WN; Li Y; Wu SF; Jin J; Wang YG; Huang H; Chen Z; Chen SJ; Tang H
J Proteome Res; 2013 Oct; 12(10):4393-401. PubMed ID: 23998518
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of ID1 gene in acute myeloid leukemia].
Lu Y; Wang Q; Mu QT; Chen ZM; Lou JY; Ni WM; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):278-81. PubMed ID: 22781717
[TBL] [Abstract][Full Text] [Related]
6. Serum metabonomics of acute leukemia using nuclear magnetic resonance spectroscopy.
Musharraf SG; Siddiqui AJ; Shamsi T; Choudhary MI; Rahman AU
Sci Rep; 2016 Aug; 6():30693. PubMed ID: 27480133
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
8. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
9. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels.
Sanchez-Correa B; Bergua JM; Campos C; Gayoso I; Arcos MJ; Bañas H; Morgado S; Casado JG; Solana R; Tarazona R
Cytokine; 2013 Mar; 61(3):885-91. PubMed ID: 23357299
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of leukemia-associated phenotype in correlation with other biologic markers in acute myeloid leukemia patients].
Dăscălescu A; Zlei M; Grigore G; Dănăila C; Jitaru D; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1176-81. PubMed ID: 20191895
[TBL] [Abstract][Full Text] [Related]
13. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
Chen WL; Wang JH; Zhao AH; Xu X; Wang YH; Chen TL; Li JM; Mi JQ; Zhu YM; Liu YF; Wang YY; Jin J; Huang H; Wu DP; Li Y; Yan XJ; Yan JS; Li JY; Wang S; Huang XJ; Wang BS; Chen Z; Chen SJ; Jia W
Blood; 2014 Sep; 124(10):1645-54. PubMed ID: 25006128
[TBL] [Abstract][Full Text] [Related]
14. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
[TBL] [Abstract][Full Text] [Related]
15. Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.
Nicolas E; Ramus C; Berthier S; Arlotto M; Bouamrani A; Lefebvre C; Morel F; Garin J; Ifrah N; Berger F; Cahn JY; Mossuz P
Leukemia; 2011 Jan; 25(1):57-65. PubMed ID: 21072048
[TBL] [Abstract][Full Text] [Related]
16. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
17. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
19. A high serum uric acid level is associated with poor prognosis in patients with acute myeloid leukemia.
Yamauchi T; Negoro E; Lee S; Takai M; Matsuda Y; Takagi K; Kishi S; Tai K; Hosono N; Tasaki T; Ikegaya S; Inai K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Anticancer Res; 2013 Sep; 33(9):3947-51. PubMed ID: 24023333
[TBL] [Abstract][Full Text] [Related]
20. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.
Terwijn M; van Putten WL; Kelder A; van der Velden VH; Brooimans RA; Pabst T; Maertens J; Boeckx N; de Greef GE; Valk PJ; Preijers FW; Huijgens PC; Dräger AM; Schanz U; Jongen-Lavrecic M; Biemond BJ; Passweg JR; van Gelder M; Wijermans P; Graux C; Bargetzi M; Legdeur MC; Kuball J; de Weerdt O; Chalandon Y; Hess U; Verdonck LF; Gratama JW; Oussoren YJ; Scholten WJ; Slomp J; Snel AN; Vekemans MC; Löwenberg B; Ossenkoppele GJ; Schuurhuis GJ
J Clin Oncol; 2013 Nov; 31(31):3889-97. PubMed ID: 24062400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
